Astal Lab, a company in the Pharmaceuticals industry, reported revenue of ₹108 crore and net profit of ₹9.77 crore for the September 2026 quarter.
Astal Lab (BSE: ASTALLTD) closed at ₹58.67 on 20 Nov 2026, down 31.8% over the past year. Its market capitalisation is ₹257 crore and it trades at 8.8 times earnings.
Incorporated in 1993, Astal Laboratories Ltd is engaged in the manufacture and sale of Pharmaceutical Intermediates and Bulk Drugs
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.